HIV -gp120- Fragment (254-274)
|
CYS-THR-HIS-GLY-ILE-ARG-PRO-VAL-VAL-SER-THR-GLN-LEU-LEU-LEU-ASN-GLY-SER-LEU-ALA-GLU
|
113944-46-0
|
HIV -gp120- Fragment (421-438)
|
HIV (GP120) FRAGMENT (421-438)
|
129318-38-3
|
HIV Integrase Protein Inhibitor(1)
|
H-HIS-CYS-LYS-PHE-TRP-TRP-OH
|
172546-75-7
|
HIV Nef(90 - 100)
|
PHE-LEU-LYS-GLU-LYS-GLY-GLY-LEU-GLU-GLY-LEU
|
|
HIV Protease Substrate
|
|
|
HIV QK10
|
GLN-VAL-PRO-LEU-ARG-MET-THR-TYR-LYS
|
|
HIV-1 env Protein gp120 (278-292) (strains BH10, BH8, HXB2, HXB3, PV22)
|
ARG-ILE-GLN-ARG-GLY-PRO-GLY-ARG-ALA-PHE-VAL-THR-ILE-GLY-LYS
|
114991-28-5
|
HIV-1 gag Protein p24 (137-154)
|
GLY-LEU-ASN-LYS-ILE-VAL-ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU-ASP-ILE-ARG
|
|
HIV-1 rev Protein (34-50)
|
HIV-1 REV PROTEIN (34-50)
|
141237-50-5
|
HIV-1 tat Protein (1-9)
|
HIV-1 TAT PROTEIN (1-9)
|
200203-20-9
|
HIV-1 tat Protein (47-57)
|
HIV-1 TAT PROTEIN (47-57)
|
191936-91-1
|
HIV-1, HIV-2 Protease Substrate
|
ALA-THR-LEU-ASN-PHE-PRO-ILE-SER-PRO-TRP
|
|
HIV-gp120- Fragment (308-331)
|
ASN-ASN-THR-ARG-LYS-SER-ILE-ARG-ILE-GLN-ARG-GLY-PRO-GLY-ARG-ALA-PHE-VAL-THR-ILE-GLY-LYS-ILE-GLY
|
115416-08-5
|
HIV-gp120-41-C
|
VAL-PRO-TRP-ASN-SER-SER-TRP-SER-ASN-LYS-LEU-ASP-ARG-ILE-TRP-ASN-ASN-MET-THR-TRP
|
|
HIV-gp120-41-N-A
|
LEU-TRP-VAL-THR-VAL-TYR-TYR-GLY-VAL-PRO-VAL-TRP-LYS-LYS-VAL-VAL
|
|
HIV-gp120-41-N-B
|
ILE-GLU-PRO-LEU-GLY-ILE-ALA-PRO-THR-LYS-ALA-LYS-ARG-ARG-VAL-VAL-GLN-ARG-GLU-LYS-ARG
|
|
HIV-gp120-Fragment (318-327)
|
ARG-GLY-PRO-GLY-ARG-ALA-PHE-VAL-THR-ILE
|
147841-68-7
|
HIV-gp41-Fragment
|
艾滋病病毒(抗原)
|
129426-47-7
|
HJ Inhibitor Peptide 2
|
LYS-TRP-TRP-CYS-ARG-TRP
|
|
H-Leu-Phe-OH
|
H-LEU-PHE-OH
|
3063-05-6
|
H-Lys-Leu-OH
|
H-LYS-LEU-OH
|
103404-72-4
|
H-LYS-THR-GLU-GLU-ILE-SER-GLU-VAL-ASN-STA-VAL-ALA-GLU-PHE-OH
|
H-LYS-THR-GLU-GLU-ILE-SER-GLU-VAL-ASN-STA-VAL-ALA-GLU-PHE-OH
|
350228-37-4
|
HMPA-AM Resin
|
HMPA-AM RESIN
|
|
H-N-Me-D-Ala-OH
|
H-N-ME-D-ALA-OH
|
|
H-N-Me-Pro-OH
|
|
|
H-Phe(4-CN)-OH
|
L-4-氰基苯丙氨酸
|
167479-78-9
|
H-Phg(4-OH)-OH
|
|
|
H-Pro-Hyp-OH
|
4-羟基-1-L-脯氨酰-L-脯氨酸
|
18684-24-7
|
HPV-E6-M
|
SER-GLU-TYR-PRO-HIS-TYR-CYS-TYR-SER-LEU-TYR-GLY-THR-THR-LEU-GLU-GLN-GLN-TYR-ASN
|
|
HPV-E7-N
|
TYR-MET-LEU-ASP-LEU-GLN-PRO-GLU-THR-THR-ASP-LEU-TYR-CYS-TYR-GLU-GLN-LEU-ASN-ASP
|
|
Hsp Heat shock protein (3-13)
|
LYS-THR-ILE-ALA-TYR-ASP-GLU-GLU-ALA-ARG-ARG
|
|
HSV-1 Glycoprotein (gB) (497-507)
|
THR-SER-SER-ILE-GLU-PHE-ALA-ARG-LEU-GLN-PHE
|
148337-11-5
|
HSV-1-amide UL 26 Open Reading Frame (242-255)
|
H-HIS-THR-TYR-LEU-GLN-ALA-SER-GLU-LYS-PHE-LYS-MET-TRP-GLY-NH2
|
396716-24-8
|
HSV-gB2 (498 - 505)
|
SER-SER-ILE-GLU-PHE-ALA-ARG-LEU
|
149997-91-1
|
H-Thr-Obzl
|
|
|
H-Thr-Ome(Oil)
|
|
|
H-Tyr(Bzl)-OMe
|
|
|
Human CMV Assemblin Protease Substrate (M-site)
|
ARG-GLY-VAL-VAL-ASN-ALA-SER-SER-ARG-LEU-ALA-LYS
|
|
Human CMV pp65 (495-503)
|
ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL
|
153045-21-7
|
Human Follicular Conadotropin Releasing Peptide (Hf-GRP)
|
|
|
Human IgE Pentapeptide HEPP
|
喷替吉肽
|
62087-72-3
|
Humanin (human)
|
护脑素(人体)
|
330936-69-1
|
H-Val-Val-OH
|
H-VAL-VAL-OH
|
3918-94-3
|
Hydrin 1
|
CYS-TYR-ILE-GLN-ASN-CYS-PRO-ARG-GLY-GLY-LYS-ARG (DISULFIDE BRIDGE: CYS1-CYS6)
|
148440-73-7
|
Hypercalcemia Malignancy Factor (1-40)
|
ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-GLU-ILE-ARG-ALA-THR-SER
|
120298-73-9
|
Hypertrehalosaemic Neuropeptide, Heliothis zea
|
PYR-LEU-THR-PHE-SER-SER-GLY-TRP-GLY-ASN-NH2
|
117107-54-7
|
Hypertrehalosaemic Neuropeptide, Nauphoeta cinerea
|
HYPERTREHALOSAEMIC NEUROPEPTIDE (NAUPHOETA CINEREA)
|
106018-36-4
|
Hypocretin (70-98) (human)
|
HYPOCRETIN (70-98) (HUMAN)
|
1129545-33-0
|
I-309 (human)
|
LYS-SER-MET-GLN-VAL-PRO-PHE-SER-ARG-CYS-CYS-PHE-SER-PHE-ALA-GLU-GLN-GLU-ILE-PRO-LEU-ARG-ALA-ILE-LEU-CYS-TYR-ARG-ASN-THR-SER-SER-ILE-CYS-SER-ASN-GLU-GLY-LEU-ILE-PHE-LYS-LEU-LYS-ARG-GLY-LYS-GLU-ALA-CYS-ALA-LEU-ASP-THR-VAL-GLY-TRP-VAL-GLN-ARG-HIS-ARG-LYS-MET
|
|
IELLQAR (8 - branch MAPS) Selectin Binding Peptide
|
ILE-GLU-LEU-LEU-GLN-ALA-ARG
|
|
IGF-I (24-41)
|
TYR-PHE-ASN-LYS-PRO-THR-GLY-TYR-GLY-SER-SER-SER-ARG-ARG-ALA-PRO-GLN-THR
|
135861-49-3
|
IGF-I (30-41)
|
GLY-TYR-GLY-SER-SER-SER-ARG-ARG-ALA-PRO-GLN-THR
|
82177-09-1
|
IGF-I Analog
|
CYS-TYR-ALA-ALA-PRO-LEU-LYS-PRO-ALA-LYS-SER-CYS
|
147819-32-7
|
IGF-II (33-40)
|
SER-ARG-VAL-SER-ARG-ARG-SER-ARG
|
103244-41-3
|
IL-1 Receptor Peptide (human)
|
IL-1 RECEPTOR PEPTIDE (HUMAN)
|
141801-03-8
|
IL-1a (223-250) (human)
|
PHE-PHE-TYR-GLU-THR-HIS-GLY-THR-LYS-ASN-TYR-PHE-THR-SER-VAL-ALA-HIS-PRO-ASN-LEU-PHE-ILE-ALA-THR-LYS-GLN-ASP-TYR
|
|
IL-1b (178-207) (human)
|
LEU-LYS-GLU-LYS-ASN-LEU-TYR-LEU-SER-CYS-VAL-LEU-LYS-ASP-ASP-LYS-PRO-THR-LEU-GLN-LEU-GLU-SER-VAL-ASP-PRO-LYS-ASN-TYR-PRO
|
|
IL-1b (208-240) (human)
|
LYS-LYS-LYS-MET-GLU-LYS-ARG-PHE-VAL-PHE-ASN-LYS-ILE-GLU-ILE-ASN-ASN-LYS-LEU-GLU-PHE-GLU-SER-ALA-GLN-PHE-PRO-ASN-TRP-TYR-ILE-SER-THR
|
|
IL-6 (88-121) (human)
|
ILE-ILE-THR-GLY-LEU-LEU-GLU-PHE-GLU-VAL-TYR-LEU-GLU-TYR-LEU-GLN-ASN-ARG-PHE-GLU-SER-SER-GLU-GLU-GLN-ALA-ARG-ALA-VAL-GLN-MET-SER-THR-LYS
|
145990-81-4
|
IL-8 (-5 to +5)
|
ALA-VAL-LEU-PRO-ARG-SER-ALA-LYS-GLU-LEU
|
|
IL-8 Inhibitor
|
AC-ARG-ARG-TRP-TRP-CYS-ARG- NH2
|
138559-60-1
|
IL-8ra (9-29)
|
AC-MET-TRP-ASP-PHE-ASP-ASP-LEU-ASN-PHE-THR-GLY-MET-PRO-PRO-ALA-ASP-GLU-ASP-TYR-SER-PRO-NH2
|
188689-66-9
|
Influenza A M2 coat protein (22 - 46)
|
SER-SER-ASP-PRO-LEU-VAL-VAL-ALA-ALA-SER-ILE-ILE-GLY-ILE-LEU-HIS-LEU-ILE-LEU-TRP-ILE-LEU-ASP-ARG-LEU
|
|
Influenza A NP (366 - 374)
|
ALA-SER-ASN-GLU-MET-ASN-ASP-ALA-MET
|
|
Influenza HA (110 - 120)
|
SER-PHE-GLU-ARG-PHE-GLU-ILE-PHE-PRO-LYS-GLU
|
|
Influenza HA (210 - 219)
|
THR-TYR-VAL-SER-VAL-GLY-THR-SER-THR-LEU
|
|
Influenza HA (518 - 526)
|
ILE-TYR-SER-THR-VAL-ALA-SER-SER-LEU
|
186302-15-8
|
Influenza HA (529 - 537)
|
ILE-TYR-ALA-THR-VAL-ALA-GLY-SER-LEU
|
|
Influenza NP (147 - 155)
|
THR-TYR-GLN-ARG-THR-ARG-ALA-LEU-VAL
|
132326-72-8
|
Influenza NP (482 - 489)
|
SER-ASN-GLU-GLY-SER-TYR-PHE-PHE
|
|
Influenza NP (50 - 57)
|
SER-ASP-TYR-GLU-GLY-ARG-LEU-ILE
|
|
Insulin B (9-23)
|
NH2-SHLVEALYLVCGERG-OH
|
|
Insulin-like Growth Factor I (57-70)
|
ALA-LEU-LEU-GLU-THR-TYR-CYS-ALA-THR-PRO-ALA-LYS-SER-GLU
|
|
Interleukin II (60-70)
|
LEU-THR-PHE-LYS-PHE-TYR-MET-PRO-LYS-LYS-ALA
|
|
Interleukin-6 Receptor (partial)
|
THR-SER-LEU-PRO-VAL-GLN-ASP-SER-SER-SER-VAL-PRO
|
|
IP3R - derived Peptide
|
GLY-ARG-ARG-GLU-SER-LEU-THR-SER-PHE-GLY-NH2
|
|
IRL-1720
|
AC-ASP-LYS-GLU-ALA-VAL-TYR-PHE-ALA-HIS-LEU-ASP-ILE-ILE-TRP
|
|
Kallikrein Inhibitor
|
AC-PRO-PHE-ARG-SER-VAL-GLN-NH2
|
|
KEEAE
|
LYS-GLU-GLU-ALA-GLU
|
100929-96-2
|
Kemptide Negative Control
|
LEU-ARG-ARG-ALA-ALA-LEU-GLY
|
|
Ketolide resistance Peptide MRFFV
|
H-MET-ARG-PHE-PHE-VAL-OH
|
|
K-G-D-S
|
H-LYS-GLY-ASP-SER-OH
|
93674-95-4
|
KGF Receptor Peptide
|
HIS-SER-GLY-ILE-ASN-SER-SER-ASN-ALA-GLU-VAL-LEU-ALA-LEU-PHE-ASN-VAL-THR-GLU-MET-ASP-ALA-GLY-GLU-TYR
|
161338-76-7
|
Kinase Domain of Insulin Receptor (1)
|
TYR-GLU-THR-ASP-PTYR-TYR-ARG-LYS-GLY-GLY-LYS-GLY-LEU
|
|
Kinase Domain of Insulin Receptor (2)
|
THR-ARG-ASP-ILE-PTYR-GLU-THR-ASP-TYR-TYR-ARG-LYS
|
|
Kinase Domain of Insulin Receptor (3)
|
THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-PTYR-TYR-ARG-LYS
|
|
Kinase Domain of Insulin Receptor (4)
|
THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-TYR-PTYR-ARG-LYS
|
|
Kinase Domain of Insulin Receptor (5)
|
THR-ARG-ASP-ILE-PTYR-GLU-THR-ASP-PTYR-PTYR-ARG-LYS
|
|
Kinase Domain of Pyruvate Kinase, porcine liver
|
LEU-ARG-ARG-ALA-PSER-LEU-GLY
|
|
Kisspeptin-13 (4-13) (human)
|
Kisspeptin-10
|
374675-21-5
|
Kisspeptin-13 (human)
|
LEU-PRO-ASN-TYR-ASN-TRP-ASN-SER-PHE-GLY-LEU-ARG-PHE-NH2
|
374675-18-0
|
Kisspeptin-54 (27-54) (human)
|
KISS-1 (94-121) (HUMAN)
|
1135442-77-1
|
KK4A
|
LYS-LYS-GLY-SER-VAL-VAL-ILE-VAL-GLY-ARG-ILE-VAL-LEU-SER-GLY-LYS
|
|
KL-1
|
LEU-PRO-PRO-VAL-ALA-ALA-SER-SER-LEU-ARG-ASN-ASP
|
|
H-Glu-OtBu
|
H-GLU-OTBU
|
|
H-Gly-Hyp-OH
|
H-GLY-HYP-OH
|
24587-32-4
|
H-Gly-Met-OH
|
H-GLY-MET-OH
|
554-94-9
|
H-His(Bzl)-OH
|
H-HIS(BZL)-OH
|
26086-41-9
|
Histatin 3 (H3)
|
ASP-SER-HIS-ALA-LYS-ARG-HIS-HIS-GLY-TYR-LYS-ARG-LYS-PHE-HIS-GLU-LYS-HIS-HIS-SER-HIS-ARG-GLY-TYR-ARG-SER-ASN-TYR-LEU-TYR-ASP-ASN
|
|
Histatin 5
|
组蛋白5
|
104339-66-4
|